17q21-qter trisomy is an indicator of poor prognosis in acute myelogenous leukemia

被引:6
作者
Morerio, C
Russo, I
Rosanda, C
Rapella, A
Leszl, A
Basso, G
Maserati, E
Pasquali, F
Panarello, C
机构
[1] Ist Giannina Gaslini, Div Ematol & Oncol Pediat, I-16147 Genoa, Italy
[2] Univ Padua, Dipartimento Pediat Clin Pediat, Padua, Italy
[3] Univ Turin, Dipartimento Pediat, I-10124 Turin, Italy
[4] Univ Pavia, I-27100 Pavia, Italy
关键词
D O I
10.1016/S0165-4608(99)00229-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A reciprocal translocation (9;11) is often found in acute myeloid leukemia (AML), mostly of the M5a type. We report a case of a child with ARAL, in whom r(9;11) was observed at diagnosis as the sole structural abnormality, together vith trisomies 19 and 21. The diagnosis was AML evolving from a myelodysplastic syndrome (MDS), and the blast morphology was undifferentiated. Chemotherapy failed to induce morphological remission and the patient's condition soon worsened. A subclone appeared and expanded during the course of the disease, with an additional unbalanced translocation (1;17) leading to trisomy of the long arm of chromosome 17 (17q). The data available from the literature on acquired anomalies involving 17q and our observation led us to postulate a specific link; between the gain of 17q and complete chemoresistance. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:12 / 15
页数:4
相关论文
共 25 条
[1]   THE KARYOTYPE OF BLASTIC CRISIS [J].
ALIMENA, G ;
DECUIA, MR ;
DIVERIO, D ;
GASTALDI, R ;
NANNI, M .
CANCER GENETICS AND CYTOGENETICS, 1987, 26 (01) :39-50
[2]   HIGH-DENSITY GENETIC-MAP OF THE BRCA1 REGION OF CHROMOSOME-17Q12-Q21 [J].
ANDERSON, LA ;
FRIEDMAN, L ;
OSBORNELAWRENCE, S ;
LYNCH, E ;
WEISSENBACH, J ;
BOWCOCK, A ;
KING, MC .
GENOMICS, 1993, 17 (03) :618-623
[3]   MOLECULAR-BASIS OF 11Q23 REARRANGEMENTS IN HEMATOPOIETIC MALIGNANT PROLIFERATIONS [J].
BERNARD, OA ;
BERGER, R .
GENES CHROMOSOMES & CANCER, 1995, 13 (02) :75-85
[4]   Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma [J].
Bown, N ;
Cotterill, S ;
Lastowska, M ;
O'Neill, S ;
Pearson, ADJ ;
Plantaz, D ;
Meddeb, M ;
Danglot, G ;
Brinkschmidt, C ;
Christiansen, H ;
Laureys, G ;
Speleman, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (25) :1954-1961
[5]   ALLELIC LOSS OF CHROMOSOME-1 AND ADDITIONAL CHROMOSOME-17 MATERIAL ARE BOTH UNFAVORABLE PROGNOSTIC MARKERS IN NEUROBLASTOMA [J].
CARON, H .
MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 24 (04) :215-221
[6]   The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial [J].
Grimwade, D ;
Walker, H ;
Oliver, F ;
Wheatley, K ;
Harrison, C ;
Harrison, G ;
Rees, J ;
Hann, I ;
Stevens, R ;
Burnett, A ;
Goldstone, A .
BLOOD, 1998, 92 (07) :2322-2333
[7]   ASSOCIATION OF 17P LOSS WITH LATE-STAGE OR REFRACTORY DISEASE IN HEMATOLOGIC MALIGNANCY [J].
HAWKINS, JM ;
MOORMAN, AV ;
HOFFBRAND, AV ;
MARTINEAU, M ;
WRIGHT, FS ;
MEHTA, AB ;
PRENTICE, HG ;
SECKERWALKER, LM .
CANCER GENETICS AND CYTOGENETICS, 1994, 77 (02) :134-143
[8]  
Joh T, 1996, ONCOGENE, V13, P1945
[9]   TRISOMY-19 AS THE SOLE CHROMOSOMAL ANOMALY IN HEMATOLOGIC NEOPLASMS [J].
JOHANSSON, B ;
BILLSTROM, R ;
MAURITZSON, N ;
MITELMAN, F .
CANCER GENETICS AND CYTOGENETICS, 1994, 74 (01) :62-65
[10]   Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients [J].
Lastowska, M ;
Cotterill, S ;
Pearson, ADJ ;
Roberts, P ;
McGuckin, A ;
Lewis, I ;
Bown, N .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (10) :1627-1633